Overview

The Safety and Efficacy of an Enzyme Combination in Managing Knee Osteoarthritis Pain in Adults

Status:
Completed
Trial end date:
2001-11-01
Target enrollment:
Participant gender:
Summary
The aim of this randomized, double-blind, placebo-controlled, comparator-controlled trial was to evaluate the safety and efficacy of an enzyme combination, as Wobenzym®, in adults with moderate-to-severe osteoarthritis (OA) of the knee.
Phase:
Phase 2
Details
Lead Sponsor:
Atrium Innovations
Collaborator:
Mucos Pharma GmbH, Oberhaching, Germany
Treatments:
Diclofenac
Wobenzym